X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (375) 375
Book Review (85) 85
Publication (30) 30
Book / eBook (10) 10
Web Resource (3) 3
Conference Proceeding (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (369) 369
index medicus (356) 356
male (242) 242
female (235) 235
middle aged (232) 232
aged (204) 204
paraproteinemias - epidemiology (193) 193
adult (164) 164
aged, 80 and over (114) 114
hematology (102) 102
paraproteinemias - complications (93) 93
paraproteinemias - diagnosis (86) 86
monoclonal gammopathy (85) 85
prevalence (83) 83
multiple-myeloma (80) 80
risk factors (80) 80
multiple myeloma (79) 79
retrospective studies (73) 73
multiple myeloma - epidemiology (67) 67
abridged index medicus (62) 62
paraproteinemias - immunology (61) 61
paraproteinemias - pathology (53) 53
undetermined significance (53) 53
oncology (51) 51
incidence (49) 49
prognosis (45) 45
adolescent (44) 44
follow-up studies (44) 44
risk (41) 41
disease progression (40) 40
paraproteinemias - blood (40) 40
paraproteinemia (39) 39
medicine, general & internal (38) 38
diagnosis, differential (34) 34
paraproteinemias - etiology (34) 34
multiple myeloma - diagnosis (33) 33
cancer (31) 31
diagnosis (31) 31
cohort studies (30) 30
mgus (29) 29
paraproteinemias - genetics (29) 29
clinical neurology (28) 28
epidemiology (28) 28
paraproteinemias (28) 28
monoclonal gammopathies (27) 27
paraproteinemias - therapy (26) 26
comorbidity (24) 24
monoclonal gammopathy of undetermined significance (24) 24
myeloma (24) 24
paraproteinemias - physiopathology (24) 24
child (23) 23
care and treatment (22) 22
follow-up (22) 22
immunoglobulins (22) 22
multiple myeloma - etiology (22) 22
disease (21) 21
long-term (21) 21
neurosciences (21) 21
research (21) 21
case-control studies (20) 20
immunology (20) 20
multiple myeloma - complications (20) 20
peripheral neuropathy (20) 20
polyneuropathy (20) 20
age distribution (19) 19
age factors (19) 19
immunoglobulin g - blood (19) 19
medical research (19) 19
monoclonal gammopathy of undetermined significance - epidemiology (18) 18
proteins (18) 18
time factors (18) 18
young adult (18) 18
hemic and lymphatic diseases (17) 17
immunoglobulin light chains - blood (17) 17
immunoglobulin m - immunology (17) 17
internal medicine (17) 17
medicine & public health (17) 17
multiple myeloma - pathology (17) 17
survival analysis (17) 17
amyloidosis (16) 16
immunoglobulin g (16) 16
immunoglobulin m - blood (16) 16
lymphoproliferative disorders - epidemiology (16) 16
survival (16) 16
waldenstrom macroglobulinemia - epidemiology (16) 16
analysis (15) 15
antibodies (15) 15
biopsy (15) 15
bone marrow - pathology (15) 15
child, preschool (15) 15
gammopathy (15) 15
multiple myeloma - immunology (15) 15
paraproteinemias - mortality (15) 15
serum (15) 15
therapy (15) 15
treatment outcome (15) 15
united-states (15) 15
urology & nephrology (15) 15
immunoelectrophoresis (14) 14
immunosuppressive agents - therapeutic use (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (336) 336
French (17) 17
Spanish (11) 11
German (9) 9
Japanese (7) 7
Italian (4) 4
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Muscle & Nerve, ISSN 0148-639X, 05/2016, Volume 53, Issue 5, pp. 683 - 689
IntroductionMany patients treated with intravenous immunoglobulin (IVIg) are>60 years of age. Tolerability has yet to be demonstrated in this age group.... 
side effect | dose | sucrose | CIDP | intravenous immunoglobulin | elderly | Intravenous immunoglobulin | Sucrose | Dose | Elderly | Side effect | CONTROLLED-TRIAL | IMMUNE GLOBULIN | GAMMA-GLOBULIN | IVIG | INFLAMMATORY DEMYELINATING POLYNEUROPATHY | AUTOIMMUNE DISORDERS | NEUROSCIENCES | CLINICAL NEUROLOGY | MULTIFOCAL MOTOR NEUROPATHY | THERAPY | POLYRADICULONEUROPATHY | THROMBOEMBOLIC COMPLICATIONS | Age Factors | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Male | Neuromuscular Diseases - drug therapy | Renal Insufficiency, Chronic - epidemiology | Young Adult | Paraproteinemias - epidemiology | Overweight - epidemiology | Hypertension - chemically induced | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Guillain-Barre Syndrome - epidemiology | Aged, 80 and over | Adult | Female | Acute Kidney Injury - chemically induced | Retrospective Studies | Hypertension - epidemiology | Headache - chemically induced | Heart Failure - epidemiology | Peripheral Nervous System Diseases - epidemiology | Drug Eruptions - etiology | Myasthenia Gravis - epidemiology | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - epidemiology | Comorbidity | Guillain-Barre Syndrome - drug therapy | Risk Factors | Drug-Related Side Effects and Adverse Reactions - epidemiology | Immunoglobulins, Intravenous - therapeutic use | Diabetes Mellitus - epidemiology | Venous Thrombosis - epidemiology | Adolescent | Aged | Immunologic Factors - adverse effects | Neuromuscular Diseases - epidemiology | Myasthenia Gravis - drug therapy | Peripheral Nervous System Diseases - drug therapy | Cohort Studies | Immunologic Factors - therapeutic use | Immunoglobulins | Nervous system diseases | Safety and security measures | Risk factors | Health risk assessment | Age | Index Medicus
Journal Article
La Revue du praticien, ISSN 0035-2640, 09/2018, Volume 68, Issue 7, p. 785
Journal Article
Kidney International, ISSN 0085-2538, 03/2017, Volume 91, Issue 3, pp. 691 - 698
Thrombotic microangiopathy (TMA) is a rare disease comprising of a diverse set of disorders linked by a common histologic finding of endothelial injury.... 
kidney | TTP | monoclonal gammopathy | HUS | aHUS | thrombotic microangiopathy | M protein | MULTIPLE-MYELOMA | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | CHAIN PROXIMAL TUBULOPATHY | PREVALENCE | ALTERNATIVE PATHWAY | PROLIFERATIVE GLOMERULONEPHRITIS | UNDETERMINED SIGNIFICANCE | UROLOGY & NEPHROLOGY | THROMBOCYTOPENIC PURPURA | SPECTRUM | Prevalence | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | POEMS Syndrome - therapy | Plasma Exchange | Thrombotic Microangiopathies - epidemiology | Minnesota - epidemiology | Multiple Myeloma - therapy | Paraproteinemias - epidemiology | Time Factors | POEMS Syndrome - diagnosis | Aged, 80 and over | Adult | Female | Leukemia, T-Cell - epidemiology | Retrospective Studies | POEMS Syndrome - epidemiology | Kidney - physiopathology | Multiple Myeloma - epidemiology | Paraproteinemias - immunology | Glomerular Filtration Rate | Kidney Failure, Chronic - surgery | Multiple Myeloma - diagnosis | Paraproteinemias - diagnosis | Risk Factors | Paraproteinemias - therapy | Treatment Outcome | Kidney Transplantation | Biomarkers - blood | Disease Progression | Leukemia, T-Cell - diagnosis | Kidney Failure, Chronic - epidemiology | Biopsy | Thrombotic Microangiopathies - therapy | Thrombotic Microangiopathies - diagnosis | Aged | Leukemia, T-Cell - therapy | Renal Dialysis | Index Medicus
Journal Article
MAYO CLINIC PROCEEDINGS, ISSN 0025-6196, 08/2009, Volume 84, Issue 8, pp. 685 - 693
Journal Article
Medicine (United States), ISSN 0025-7974, 08/2015, Volume 94, Issue 32, pp. e1275 - e1275
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 2013, Volume 84, Issue 11, pp. 1282 - 1287
Journal Article
International Journal of Cancer, ISSN 0020-7136, 06/2006, Volume 118, Issue 12, pp. 3095 - 3098
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 03/2016, Volume 11, Issue 3, pp. 431 - 441
Background and objectives Monoclonal gammopathies (MGs) with renal involvement can lead to ESRD caused by myeloma cast nephropathy (MCN), immunoglobulin light... 
light chain deposition disease | chronic kidney disease | multiple myeloma | amyloidosis | end stage kidney disease | paraproteinemias | monoclonal gammopathy | kidney transplantation | humans | renal dialysis | INVOLVEMENT | DISEASE CLASSIFICATION | UROLOGY & NEPHROLOGY | DEPOSITION DISEASE | SYSTEMIC AMYLOIDOSIS | BORTEZOMIB | FAILURE | HIGH-DOSE DEXAMETHASONE | EPIDEMIOLOGY | TRANSPLANTATION | REGISTRY | Kidney Failure, Chronic - mortality | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Cause of Death | Recovery of Function | Incidence | Amyloidosis - epidemiology | Renal Dialysis - mortality | Renal Dialysis - trends | Time Factors | Aged, 80 and over | Female | Registries | Kidney - physiopathology | Kidney Failure, Chronic - physiopathology | Multiple Myeloma - epidemiology | France - epidemiology | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Amyloidosis - mortality | Treatment Outcome | Kidney Transplantation | Amyloidosis - blood | Kidney Failure, Chronic - therapy | Kidney Failure, Chronic - epidemiology | Renal Dialysis - adverse effects | Aged | Immunoglobulin Light Chains - blood | Index Medicus | Life Sciences | Human health and pathology | Psychology | Santé publique et épidémiologie | Humanities and Social Sciences | Economies and finances | Psychiatrics and mental health | Original
Journal Article